|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2000-7-21
|
|
pubmed:abstractText |
Dysphonia is a known local adverse effect of inhaled corticosteroids. This symptom was investigated by laryngoscopy and assessment in a voice laboratory. The effects of changing the treatment of patients with dysphonia, reported whilst using the pMDI, to pMDI plus Nebuhaler or Tubuhaler was also assessed.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0954-6111
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
94
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
448-53
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10868708-Administration, Inhalation,
pubmed-meshheading:10868708-Adult,
pubmed-meshheading:10868708-Aged,
pubmed-meshheading:10868708-Aged, 80 and over,
pubmed-meshheading:10868708-Asthma,
pubmed-meshheading:10868708-Bronchodilator Agents,
pubmed-meshheading:10868708-Budesonide,
pubmed-meshheading:10868708-Female,
pubmed-meshheading:10868708-Forced Expiratory Volume,
pubmed-meshheading:10868708-Humans,
pubmed-meshheading:10868708-Laryngoscopy,
pubmed-meshheading:10868708-Male,
pubmed-meshheading:10868708-Middle Aged,
pubmed-meshheading:10868708-Nebulizers and Vaporizers,
pubmed-meshheading:10868708-Vital Capacity,
pubmed-meshheading:10868708-Voice Disorders,
pubmed-meshheading:10868708-Voice Quality
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Comparison of Pulmicort pMDI plus Nebuhaler and Pulmicort Turbuhaler in asthmatic patients with dysphonia.
|
|
pubmed:affiliation |
Respiratory Medicine Unit, Western General Hospital, Edinburgh, UK.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
